Introduction
Granulocyte colony-stimulating factor is the major hematopoietic growth factor which controls the production and dierentiation of granulocytes (Nagata et al., 1986) . The biological eects of G-CSF are mediated by the G-CSF receptor, which is a member of the hematopoietin/cytokine receptor (HCR) superfamily (Taniguchi, 1995) . The functional receptor complex is a homodimer (Fukunaga et al., 1991) . The membrane proximal cytoplasmic domain of 57 amino acids in the G-CSFR contains Box 1 and Box 2, which are conserved among the hematopoietic/cytokine receptors and are critical for the transduction of growth signals (Ziegler et al., 1993; Sakamaki et al., 1992; Dong et al., 1993) .
Binding of G-CSF to its receptor results in rapid tyrosine phosphorylation of the receptor as well as the activation of a number of PTKs (Pan et al., 1993) . These kinases include the Janus family of kinases, Jak1 and Jak2, and the Src kinase Lyn and the non-Src kinase Syk (Nicholson et al., 1994; Corey et al., 1994; Ihle et al., 1995) . Other tyrosine kinase-dependent signaling events have been found in G-CSF-stimulated cells, such as the activation of STAT3 and STAT5 (Nicholson et al., 1994 (Nicholson et al., , 1995 Tian et al., 1994) . G-CSF also activates the Ras-MAP Kinase pathway in myeloid-derived cells (Bashey et al., 1994) . The physiological roles of the PTKs and their downstream events in G-CSF-induced signaling are unclear. To determine the function of PTKs in G-CSF signaling, we have expressed the G-CSFR in cell lines, which lack Lyn or Syk. We have observed the loss of G-CSFinduced DNA synthesis in lyn-de®cient cells. Ectopic expression of Lyn in the lyn-de®cient cells restored responsiveness to G-CSF. The lyn-de®cient cells showed G-CSF-induced activation of Jak1 and Jak2. Therefore, it appears that the Src kinase Lyn is required for G-CSF-induced DNA synthesis and that activation of Jak1 or Jak2 is not sucient for this response (Corey et al., 1998) .
The cellular proto-oncogene p21ras is an important mediator of signal transduction in mammalian cells (Satoh et al., 1992) . Ras is activated by G-CSF and other cytokines (Bashey et al., 1994; Satoh et al., 1992) . Ras is associated with the activation of a downstream serine-threonine kinase cascade that leads to the activation of Erk1/Erk2 (p44/42 MAP Kinase) and the regulation of gene expression (Wood et al., 1992; Leevers and Marshall, 1992; Nakielny et al., 1992) . While many believe that the Ras-MAP Kinase cascade serves as a main mitogenic pathway in higher eukaryotic cells, formal proof of it is lacking. We have used an experimental model of avian hematopoietic cells expressing the human G-CSFR but lacking either the Src-related kinase Lyn or the non-Src kinase Syk to determine the functional contribution of these PTKs to G-CSF's activation of the Ras-MAP Kinase pathway and to correlate that with G-CSF-induced DNA synthesis. The strength of this system is that there are no other known Src kinases present in this cell line which could substitute for Lyn, and there is no ZAP-70, which could substitute for Syk. Here, we show that both Lyn and Syk are required for full activation of the Shc-Ras-MAP Kinase pathway by G-CSF. Because Ras activatiaon occurs in lyn-de®cient cells, Ras activation alone is not sucient for G-CSFinduced proliferation. Because MAP Kinase activation does not occur in syk-de®cient cells, MAP Kinase is not necessary for proliferation. Therefore, the Ras-MAP Kinase pathway does not act as the main mitogenic one in cells responding to G-CSF. Instead, we found that G-CSF-induced tyrosine phosphorylation of Cbl and the activation of PI 3-kinase correlated with proliferation. When cells were treated with the PI 3-kinase inhibitors or expressed a dominant negative form of Shc, G-CSF-induced DNA synthesis was inhibited. These data suggest that the Lyn-dependent signaling pathways of Shc, Cbl, and PI 3-kinase, but not Ras-MAP Kinase, contribute to G-CSF-induced proliferation.
Results

G-CSF stimulation of Shc and its eect on proliferation
Because we have demonstrated that G-CSF receptor signaling requires Lyn for induction of DNA synthesis (Corey et al., 1998) , we next wished to identify Lynassociated pathways which might contribute to proliferative signaling. We ®rst examined the Ras-MAP Kinase pathway. The adaptor protein Shc becomes tyrosine phosphorylated in response to cytokine stimulation and can couple receptors with the activation of Ras via Grb2 and Sos. To assess the tyrosine phosphorylation of Shc, indicative of its activation, in response to G-CSF, cells were serumstarved and then stimulated with G-CSF. Cellular lysates were immunoprecipitated with anti-phosphotyrosine antibody and analysed by immunoblotting with antibody against Shc. In the wild-type cells, G-CSF stimulation led to rapid tyrosine phosphorylation of the p55 isoform of Shc within 1 min, which peaked at 5 ± 10 min ( Figure 1a ). G-CSF-induced tyrosine phosphorylation of Shc was absent in lyn-de®cient cells and diminished in syk-de®cient cells. Shc was present in equivalent amounts in all cell lines and can be easily distinguished from the heavy chain of Ig (Figure 1b) . These results suggest that maximal Shc phosphorylation requires both Src and Syk kinases. To determine whether Shc plays any role in G-CSF-induced DNA synthesis, wild-type DT40GR cells transfected with either the SH2 or PTB domain of Shc or an empty vector were then stimulated with varying doses of G-CSF and their DNA synthesis were measured (Baldari et al., 1995) . Expression was con®rmed by immunoblotting (data not shown). Cells expressing the dominant-negative forms of Shc did not respond as well to G-CSF or growth medium (FCS/CS) as control cells did (Figure 1c ). These studies suggest that Shc is a substrate for Lyn and that Shc contributes to G-CSFinduced DNA synthesis.
G-CSF stimulation of Ras-GTP
Wild-type DT40GR, lyn-de®cient, and syk-de®cient cells were labeled with 32 P-orthophosphate before being stimulated with G-CSF, phorbol myristyl acetate (PMA), or diluent control. PMA was used as a positive control for Ras activation. The ratio of GTP-bound Ras to GDP-bound Ras was determined by chromatographic separation of nucleotides recovered from Ras immunoprecipitates. G-CSF caused Ras activation in the wild-type DT40GR, lyn-de®cient cells, and syk-de®cient cells (Figure 2 ). Used as a control, PMA stimulation led to an increase in the proportion of GTP-bound Ras in all cell lines and ranged from 1.3 ± 2.0-fold over control values. The ability of wildtype DT40GR cells to respond to G-CSF with an increase in Ras-GTP, as has been observed in neutrophils and other myeloid-derived cells, con®rms the usefulness of this cell line as a model in studying G-CSF's signaling biochemistry. Ras activation by G-CSF in the wild-type DT40GR cells was present at 10 min (P=0.07) and reached statistically signi®cant higher levels at 30 min of stimulation (P50.05). In contrast, lyn-de®cient cells showed dierent kinetics of Ras activation following G-CSF stimulation. By 10 min, the concentration of Ras-GTP approximately doubled and returned to control levels by 30 min. Ras activation in syk-de®cient cells was similar at both 10 and 30 min (P=0.07). These kinetic dierences between cell lines may be attributable to recruitment of dierent adaptor proteins. 
G-CSF stimulation of Rsk kinase
Downstream of MAP Kinase, there is another serine kinase p90Rsk associated with a proliferative response. The presence of p90rsk could be readily detected in whole cell lysates in all three cell lines in immunoblots developed with anti-p90rsk antibody (data not shown). To assess p90rsk activation in our system, we performed a direct immunokinase assay on the cell lysates from each cell line. Cells were stimulated and immunoprecipitated with anti-p90rsk antibody, and kinase activity was measured in the resulting immune complexes against the Rsk peptide substrate RRRLSSLRA. G-CSF induced an elevated p90rsk activity (twofold at 5 min) in only the wild-type DT40GR cells (Figure 4) . Similar to what was observed for MAP Kinase activity, no G-CSF-induced increase in p90Rsk activity was seen in the lyn-de®cient and syk-de®cient cells. As positive controls, immunoprecipitates of lysates from control cells stimulated with PMA had equal p90Rsk kinase activities.
G-CSF stimulation of PI 3-kinase and Cbl and the contribution of PI 3-kinase to G-CSF-induced DNA synthesis
Wild-type DT40GR and syk-de®cient cells, but no lynde®cient cells, demonstrated *®vefold increase in PI 3-kinase activity when stimulated with G-CSF ( Figure  5a ). When compared to the magnitude in change for other G-CSF-induced biochemical responses (Ras-GTP loading or MAP Kinase activity), this increase is striking. We tested the hypothesis that PI 3-kinase Figure 2 Stimulation of Ras-bound GTP in response to G-CSF. After being labeled with inorganic 32 P, wt, lyn-de®cient, and sykde®cient cells were stimulated with or without G-CSF (100 ng/ml) or PMA (100 ng/ml) for 10 min at 378C. Following immunoprecipitation of Ras, thin layer chromatographic separation of nucleotides was performed. Following visualization by autoradiography, Ras-associated guanine nucleotides were quantitated by a Molecular Dynamics Phosphoimager and results normalized for phosphate content. The percentage ratios of GTP/GTP+GDP+s.e.m. are shown and represent the average of 4 ± 6 experiments. (*) Indicates statistical signi®cance at P50.05 and ( 6 ) at P=0.07
contributes to G-CSF proliferative signaling by treating cells with the PI 3-kinase inhibitor wortmannin, which irreversibly inhibits this lipid kinase (Vlahos et al., 1994) . The wild-type DT40GR cells were then stimulated with G-CSF and pulsed with tritiated thymidine. Wortmannin inhibited G-CSF-induced DNA synthesis in a dose-dependent manner ( Figure  5b ). Similar results were seen with LY294002, which reversibly inhibits PI 3-kinase by competing for its substrate binding site (data not shown). Through coordination of SH3 and SH2 domains with proline-rich and phosphotyrosine motifs, Lyn can couple to PI 3-kinase via an adaptor molecule, such as Cbl (Dombrosky-Ferlan and Corey, 1997; Hunter et al., 1999) . We observed that G-CSF-induced tyrosine phosphorylation of Cbl also correlated strictly with G-CSF-induced proliferation (Figure 5c ). To determine whether Cbl-associated PI 3-kinase activity was involved in G-CSF-induced proliferation, we overexpressed the CblY731F mutant in the wild-type DT40GR cells. This mutation abrogates Cbl's phosphotyrosine-dependent association with the SH2 Figure 3 Activation of p44/42 MAP kinase. Wt, lyn-de®cient, and syk-de®cient cells which express the G-CSF receptor were serumstarved and stimulated with or without G-CSF (100 ng/ml) or PMA (20 ng/ml) for 10 min at 378C in 5% CO 2 . Cellular lysates were subjected to a Mono Q anion-exchange chromatography for puri®cation of Erk 1/Erk2 Kinase. Fractions containing p44/42 MAP Kinase were incubated with myelin basic protein and [g-32 P]ATP for 50 min at 308C, applied to ®lters, acid washed, dried and quantitated. The results are presented as per cent of control. (*) Indicates statistical signi®cance dierent from control at P50.05 Figure 4 Rsk immune complex kinase assay. Following stimulation, lysates corresponding to equal numbers of starved cells were immunoprecipitated with anti-p99Rsk antibody. A kinase assay was then performed in the immune complexes against 100 mM RSK peptide (RRRLSSLRA). Cells were either stimulated with 300 ng/ml G-CSF or 20 ng/ml PMA for 10 min. Data is presented as per cent of control for each cell line and, for the G-CSF treatment, is representative of three independent experiments domain of p85 (Ueno et al., 1998) . Over-expression of the hemagglutinin-tagged CblY731F mutant was con®rmed by immunoblotting (data not shown).
Over-expression of CblY731F inhibited G-CSF-induced PI 3-kinase activity (Figure 5d ). Concomitant with the inhibition of PI 3-kinase activity in wild-type 
Discussion
The proto-oncogene product Ras and MAP Kinase serve as a main signaling pathway for the proliferation and dierentiation of metazoan cells by receptor tyrosine kinases (Leevers and Marshall, 1992) . Most hematopoietic growth factors also activate Ras-MAP kinase (Satoh et al., 1991) . Because these growth factors operate via their cognate receptors which belong to the hematopoietin/cytokine receptor superfamily, it has been postulated that receptor recruitment of cytosolic PTKs leads to activation of downstream targets like Ras (Joseph et al., 1996) . Recent studies have identi®ed adaptor proteins Shc, Grb2, and Sos as components of this pathway between the receptor and Ras-MAP Kinase (Egan and Weinberg, 1993) .
G-CSF can activate the Ras-MAP Kinase pathway, however the link between the G-CSF receptor and Ras is not known (Bashey et al., 1994) . To help resolve this issue, we have transfected an avian hematopoietic cell line, which has been mutagenized by gene targeting to lack a functional Lyn or Syk, with the cDNA for the human G-CSF receptor. All three cell lines (wild-type DT40GR, lyn-de®cient, and syk-de®cient) responded to G-CSF with changes in cellular phosphotyrosine proteins, but only the wild-type DT40GR and sykde®cient cells responded to G-CSF in a dose-dependent manner with increased tritiated-thymidine incorporation (Corey et al., 1998) . In order to investigate the role of Syk and Lyn in the Ras-MAP Kinase pathway we have examined the eect of G-CSF stimulation on Ras-GTP loading, Shc phosphorylation, and MAP Kinase and Rsk activity in our system.
Our results demonstrate that G-CSF induced the activation of Ras in all three cell lines. The magnitude of the peak and time course of activation of Ras varied between the wild-type DT40GR and lyn-de®cient cells. The activation of Ras peaked at 30 min in wild-type DT40GR cells and at 10 min in the lyn-de®cient cells. Maximal responses were 2.3-fold, a twofold, and 1.4-fold increase above unstimulated controls in wild-type DT40GR, lyn-de®cient, and syk-de®cient cells, respectively. The magnitude of change in Ras activation is comparable to that found for PMA or those reported for G-CSF induced activation of Ras in the NFS-60 cell line or for activation of Ras in a murine B cell line following B cell receptor engagement (Bashey et al., 1994; Kawauchi et al., 1994; Harwood and Cambier, 1993) . We next examined the tyrosine phosphorylation of Shc. Shc is an adaptor protein which is widely expressed in all cells and, via its phosphotyrosine residues, serves as a bridge to couple Grb2-Sos1 complexes and tyrosine kinases, thus playing a very important role in the signaling cascade leading to Ras activation Rozakis-Adcock et al., 1992) . Our results demonstrated that G-CSF stimulation induced the tyrosine phosphorylation of a p55 form of Shc in wild-type DT40GR cells and sykde®cient cells. However, the tyrosine phosphorylation was markedly reduced in the lyn-de®cient cells. Nonetheless, G-CSF was able to induce the activation of Ras in these cells. These biochemical observations suggest that Shc's phosphotyrosine residues functionally couple to Ras, independent of either its PTB or SH2 domains, or that another adaptor protein (e.g. Syp or SHP2) is involved in the linkage to the Ras-MAP Kinase pathway. Another alternative hypothesis is that Lyn and Syk are both required for maximum activation of Shc. Nagai and co-workers observed that tyrosine phosphorylation of Shc following B cell receptor engagement was absent in lyn-de®cient and decreased in syk-de®cient chicken DT40 B cells (Nagai et al., 1995) . Our observation that tyrosine phosphorylation of Shc was present but delayed following G-CSF treatment might be explained by the dierent structural properties of the homodimeric G-CSF receptor and the multimeric B cell receptor. Functional dierences also exist between the G-CSF receptor and the B cell receptor. In this cell line, engagement of the B cell receptor leads to apoptosis, while engagement of the G-CSF receptor leads to increased DNA synthesis.
Our demonstration that lyn-de®cient cells do not proliferate but have activated Ras in response to G-CSF strengthens a recent argument that Ras activation is neither necessary for nor universally found in cytokine-stimulated blood cells. Not all stimuli which lead to cell proliferation necessarily lead to Ras activation (Satoh et al., 1990a (Satoh et al., ,b, 1992 . IL-2, IL-3, and granulocyte-macrophage colony-stimulating factor (GM-CSF) activate Ras, whereas IL-4 has no eect on Ras but can cause cells to proliferate. Recent studies have shown that IL-4 stimulation of myeloid or lymphoid derived cell lines, which can proliferate in response to IL-4, induced a marginal level of tyrosine phosphorylation of a p52 form of Shc in the myeloid cell and no tyrosine phosphorylation of Shc proteins in the lymphoid cell (Welham et al., 1994a) . Furthermore, these cell lines could not activate Ras or MAP Kinase in response to IL-4 (Welham et al., 1994b) . Using a dominant negative Ras under an inducible promoter, Satoh and co-workers found that a functional Ras is dispensable for IL-3-dependent Ba/F3 cell growth (Terada et al., 1995) .
We also found that G-CSF activates MAP Kinase by 10 min in wild-type DT40GR cells but not in the lyn-de®cient or syk-de®cient cells. Demonstration of G-CSF-induced MAP Kinase activity is similar to those reported by Bashey whereby maximal activity was seen Data for DNA synthesis, Lyn kinase, Syk kinase, and Jak1/Jak2 tyrosine phosphorylation were reported in Corey et al., 1998 at 5 ± 10 min (Bashey et al., 1994) . We also examined the eect of G-CSF stimulation on the activation of a kinase immediately downstream of MAP Kinase, p90Rsk, which is phosphorylated by MAP Kinase and is co-ordinately regulated with MAP Kinase (Sturgill et al., 1988; Chung et al., 1991) . In vitro kinase and immunoblot assays were in agreement with the MAP Kinase activation data; G-CSF-induced activity was present only in the wild-type DT40GR cells. Because syk-de®cient cells respond to G-CSF with increased DNA synthesis (Corey et al., 1998) , we conclude that MAP Kinase or p90Rsk activity are not absolutely required for G-CSF-induced proliferation. The phosphorylation of Shc has been reported to be correlated with IL-2 dependent proliferation in B lymphocytes (Burns et al., 1993; Cutler et al., 1993) . While we observed a strong increase in tyrosine phosphorylation of Shc in G-CSF-treated wild-type DT40GR cells, the response was less robust in sykde®cient cells. Because expression of dominant negative forms of Shc inhibited G-CSF-induced DNA synthesis in wild-type DT40GR cells, Shc probably plays an important role in G-CSF-induced DNA synthesis via a non-Ras-dependent pathway. One candidate pathway is through the c-Jun N-terminal kinases (Hashimoto et al., 1999) .
In lyn-de®cient cells, engineered by gene targeting of either embryonic stem cells or of DT40 cells, the adaptor molecule Cbl is under-phosphorylated (Tezuka et al., 1996; Nishizumi et al., 1995) . We found that G-CSF treatment resulted in tyrosine phosphorylation of Cbl in both wild-type DT40GR and syk-de®cient cells, but not in lyn-de®cient cells. Using the yeast two hybrid technique, we recently reported that Cbl forms a trimolecular complex with Lyn and the p85 subunit of PI 3-kinase (Dombrosky-Ferlan and Corey, 1997) . With Lyn as a bait, we have also isolated Cbl in yeast two-hybrid screen of a myeloid cDNA library (A Grishin, F Jia, W Ruddert and SJ Corey, unpublished observations). We found a dramatic increase in PI 3-kinase activity in both wild-type DT40GR and sykde®cient cells. Of the biochemical events so far studied in the three cell lines (summarized in Table 1 ), tyrosine phosphorylation of Shc and Cbl and increased PI 3-kinase activity correlated with Lyn activity and G-CSF-induced DNA synthesis. Inhibition of G-CSFinduced DNA synthesis with the PI 3-kinase inhibitor wortmannin or through a dominant negative form of Cbl suggests that PI 3-kinase-dependent pathways contribute to G-CSF proliferative signaling. Similar type of experiments on thrombopoietin-stimulated cells, pretreated with wortmannin, also resulted in an inhibition of DNA synthesis (Dorsch et al., 1997) . In addition, we hypothesize that there are additional Lyndependent pathways that contribute to G-CSF proliferative signaling.
Materials and methods
Cells lines and reagents
Description of the chicken B cell line DT40 (wild-type) and the mutagenized lyn-de®cient and syk-de®cient lines has been described elsewhere (Takata et al., 1994) . The cDNA for the class I human G-CSF receptor was cloned into the pApuro eukaryotic expression vector containing the chicken actin promoter and the puromycin resistance gene for selection in eukaryotic cells. The pApuro-hG-CSFR construct was electroporated into the wild-type DT40GR, lyn-de®cient, and syk-de®cient cell lines and stable, clonal transfectants were obtained and described elsewhere (Corey et al., 1998) . The cell lines were maintained in RPMI 1640 supplemented with 10% fetal calf serum (FCS), 1% chicken serum (CS), and 1% penicillin/streptomycin, and 2 mM glutamine. The mAb against Ras (monoclonal Y13-259-Ab-1) was purchased from Oncogene Science (Uniondale, NY, USA). The mAb 4G10 (Upstate Biotechnology, Lake Placid, NY, USA) or mAb PY20 (Transduction Laboratories, Lexington, KY, USA) was used for the detection of phosphotyrosinecontaining proteins. Polyclonal anti-Shc and anti-p90Rsk penultimate C-terminus (rsk2-PCT) antibodies were purchased from Upstate Biotechnology (Lake Placid, NY, USA). Phospho-speci®c antibody against phospho-p44/42 MAP Kinase was purchased from New England Biolabs (Beverly, MA, USA). Polyclonal antibody against hemagglutinin and p85 subunit of PI 3-kinase was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Polyclonal antibody against Cbl was provided by Dr Hamid Band (Harvard Medical School). The cDNA for the SH2 or PTB domains of human Shc was kindly provided by Dr Jane McGlade (Hospital for Sick Children, Toronto, Canada) and Dr John O'Bryan (National Institute of Environmental and Health Sciences, Research Triangle, NC, USA). The cDNA for CblY731F was provided by Dr Hisamaru Hisai (University of Tokyo, Japan).
RasGTP assay
Approximately 10 7 cells were washed twice in 10 ml of phosphate-free RPMI 1640 medium before being resuspended in 1 ml of RPMI 1640 phosphate-free medium with 0.1% BSA, 1% penicillin/streptomycin, 20 mM HEPES, pH 7.5, 1% dialyzed chicken serum, plus 1 mCi/ml of 32 P-orthophosphate (New England Nuclear, Boston, MA, USA). The cells were labeled for 3 h at 378C in 5% CO 2 in 1 ml aliquots or at 10 7 cells/ml in 60 min tissue culture dishes and then treated at 378C for indicated time intervals in the presence or absence of 100 ng/ml G-CSF (Amgen, Thousand Oaks, CA, USA) or 100 ng/ml phorbol 12-myristate 13-acetate (PMA) (Sigma, St. Louis, MO, USA). The cells were harvested by centrifugation at 15 000 g for 30 s, lysed, and protein lysates prepared as described elsewhere (Clark-Lewis et al., 1991) . The resulting lysates were precleared by addition of 20 ml of a 1 : 1 slurry of protein G-agarose (Oncogene Science, Uniondale, NY, USA) for 15 min at 48C and then centrifuged at 15 000 g for 5 min at 48C. 2.5 mg anti-Ras antibody-agarose bead slurry was added to the lysate and samples were incubated for 1 h at 48C. The immunoprecipitates were washed ®ve times with 1 ml of ice cold buer (50 mM HEPES, pH 7.5, 0.5 M NaCl, 0.1% Triton X-100, 0.005% SDS, and 5 mM MgCl 2 ). Bound nucleotides were eluted by addition of 15 ml of elution buer (5 mM DTT, 5 mM EDTA, 0.2% SDS, 0.5 mM GTP/GDP) to the pellets and incubated for 20 min at 688C. Half of the sample was loaed onto PEI-F cellulose thin layer chromatography plates (Selecto Scienti®c, Norcross, GA, USA). Nucleotides were separated by solvent chromatography in 78 g/l ammonium formate, 9.6% (v/v) concentrated HCl. Guanine nucleotide standards were visualized on the TLC plates using a shortwave ultraviolet light and then radiolabeled nucleotides were visualized by autoradiography and quanti®ed using the Molecular Dynamics Phosphorimager with ImageQuant software. Per cent GTP-bound Ras was calculated using the following formula: 1006GTP/ [1.5(GDP)+GTP].
Immunoblotting and immunoprecipitation
Cells were starved of serum by washing them twice in RPMI 1640 and resuspended in stimulating medium (0.1% BSA, 1% G-CSF proliferative signalingpenicillin/streptomycin, 2 mM glutamine, 2-mercaptoethanol, and 1% chicken serum). Cells were starved for 4 ± 6 h, resuspended at 5610 6 cells/ml in 1 ml aliquots and stimulated with or without 100 ng/ml G-CSF, washed once in PBS, and solubilized in lysis buer (1% NP-40, 150 mM NaCl, 50 mM Tris-HCl, pH 7.5, 1 mM EDTA, 50 mM NaF, 1 mM Na 3 VO 4 , 10 mg/ml aprotinin, and 10 mg/ml leupeptin) for 15 min on ice. Supernatants were obtained by centrifugation at 15 000 g for 15 min at 48C and were precleared with the addition of 40 ml slurry of protein A-sepharose beads (Oncogene Science, Uniondale, NY, USA) for 15 min at 48C. Lysates were centrifuged at 15 000 g for 5 min at 48C, and then were incubated overnight at 48C with either antiphosphotyrosine (mAb 4G10 or mAb PY20), anti-Shc, or anti-Cbl antibodies. Immunoprecipitation followed with the addition of 50 ml slurry of protein A-sepharose beads for 30 min at 48C. Immunoprecipitates were washed ®ve times in ice cold lysis buer and bound proteins were released by boiling for 5 min in 26Laemmli buer. Proteins were separated on 10% SDS-polyacrylamide gels (SDS ± PAGE) and transferred onto Immobilon-P membranes (Millipore, Bedford, MA, USA). The blots were blocked with 5% dried milk in PBS at RT for 1 h and then incubated with primary antibody at RT for 1 h or overnight at 48C. Immunoblots were developed using goat anti-rabbit (Bio-Rad, Hercules, CA, USA) or donkey anti-rabbit (Jackson ImmunoResearch Laboratories, West Grove, PA, USA) secondary antibodies conjugated to horseradish peroxidase and the enhanced chemiluminescence (ECL) detection kit (Amersham, Arlington Heights, IL, USA). Relative molecular weights were calculated from blots or standards run simultaneously and stained with Ponceau S after electrophoretic transfer.
p44/42 MAP Kinase assay
Cells were serum-starved as described above and stimulated with or without 100 ng/ml G-CSF or 20 ng/ml PMA for 10 min at 378C in 5% CO 2 . Cells were processed as described above and lysates were applied to a MonoQ anion-exchange chromatography column for separation of Erk1/Erk2. Con®rmed by immunoblotting, the fractions containing p44/42 MAP Kinase were incubated with myelin basic protein (MBP, Sigma) and [g-32 P]ATP (New England Nuclear, Boston, MA, USA) for 50 min at 308C. The reaction material was applied to p81 ®lters, acid washed with 180 mM phosphoric acid, dried, and counted by scintillation. To con®rm the speci®city of MAP Kinase activity, cell lysates were assayed for their ability to phosphorylate the Erk1/Erk2 phosphorylation site in MBP, APRTPGGRR (Clark-Lewis et al., 1991) .
Rsk immunoprecipitation and immunokinase assay
Cells were harvested and resuspended in fresh RPMI 1640 at 1610 7 /ml and incubated at 378C for 5 min before being stimulated with G-CSF (300 ng/ml) or PMA (20 ng/ml). Aliquots (1.0 ml) were resuspended in 0.4 ml lysis buer (10 mM HEPES, pH 7.4, 50 mM Na 3 VO 4 , 10 mM p-nitrophenyl-phosphate, 1 mM EGTA, 1% Triton X-100, 50 mM bglycerophosphate, 10 mM phenyl-methyl-sulfonyl¯uoride (PMSF), 10 mM ammonium molybdate, 1 mM diisopropyl uorophosphate (DFP) (Aldrich, Milwaukee, WI, USA), and 1 mg/ml each of leupeptin, aprotinin, and pepstatin A. The amount of protein in lysates was between 1 ± 1.4 mg/ml. Cell lysates were incubated on ice for 20 min and then centrifuged for 5 min at 7000 g. Immunoprecipitation was carried out as reported previously with some minor modi®cations that are described in detail as follows (Halberg et al., 1994) . The primary antibody (anti-p90Rsk penultimate C-terminus, 10 mg/ml ®nal concentration) was incubated overnight with anti-rabbit (IgG, whole molecule) (Sigma) antibody conjugated to agarose beads in lysis buer (see above). The beads were thoroughly washed, then mixed with crude cell lysates at a ratio of agarose beads/cell lysates 1 : 2 (vol/vol) and incubated for 4 h at 48C and immune complexes were recovered by centrifugation. Pellets were washed twice with lysis buer and twice with buer A (100 mM Tris-HCl, pH 7.4, 400 mM LiCl) and an additional two times in buer B (10 mM Tris-HCl pH 7.4, 100 mM NaCl, 1 mM EDTA). Immune complexes were resuspended in a ®nal volume of 30 ml lysis buer and mixed with either the kinase buer (for immunokinase assay) or with gel loading buer (for PAGE and immunoblots). The enzymatic activities of p90Rsk was measured in anti-p90Rsk immunoprecipitates using the RSK peptide (RRRLSSLRA) (UBI, Lake Placid, NY, USA) as the phosphoacceptor substrate (Joseph et al., 1996) . For this purpose, 100 mM RSK peptide was diluted in freshly prepared kinase buer (13.4 mM HEPES, pH 7.3, 25 mM MgCl 2 , 30 mM Na 3 VO 4 , 5 mM p-nitrophenyl phosphate, 2 mM EGTA, 2 mM cAMP-dependent kinase inhibitor TTYADFIASGRTGRRNAIHD (Sigma), 2 mM PKC inhibitor calphostin C (Sigma), 21 mCi [g-32 P]ATP/ml (3000 Ci/ mmol) (Amersham, Arlington Heights, IL, USA) and 68 mM unlabeled ATP. One mg of cAMP-dependent kinase inhibitor inhibits 2000 ± 6000 units of PKA (equivalent to the transfer of 2 ± 6 nmol of phosphate from ATP). To initiate the phosphorylation reaction, aliquots (20 ml) of the kinase buer were mixed 1 : 1 (vol/vol) with the cell lysates. The reaction was carried out at room temperature for 10 min and terminated by blotting 20 ml of the reaction mixture onto P81 ion-exchange chromotography cellulose phosphate papers (Whatman, Hillsboro, OR, USA). Filter squares were washed, dried and counted for radioactivity.
PI 3-kinase assay
Cells were serum-starved as described above and stimulated with or without 100 ng/ml G-CSF for 10 min at 378C. Cell lysates were prepared in 1% NP40 lysis buer, as described above. PI 3-kinase activity was obtained by immunoprecipitation of cleared lysates with anti-phosphotyrosine mAb 4G10 (Ptyr) or anti-p85 antibody, followed by solid phase recovery with Protein A-Sepharose. Immunoprecipitated proteins were washed three times with PBS/1% NP40, twice with 10 mM Tris/500 mM LiCl, and twice with 10 mM Tris, 100 mM NaCl, and 1 mM EDTA. 200 mg/ml of phosphatidylinositol dissolved in DMSO (Avanti Polar Lipids, Birmingham, AL, USA) was added with 20 ml of kinase reaction buer. Reaction proceeded for 20 min before being stopped with the addition of 80 ml of 1 N HCl, and phosphatidylinositides were extracted by CHCl 3 : MeOH (1 : 1). The organic layer was spotted on silica gel plates, which were run in a chromatography tank. Phosphatidylinositol 4-phosphate (Sigma) was spotted as a control standard. Running solvent was CHCl 3 :MeOH:ddH 2 0:NH 4 OH in 60 : 47 : 11.2 : 2 ratio. Plates were exposed to ®lm and autoradiograms were analysed by densitometry.
Tritiated thymidine incorporation assay
Cells were washed in sterile PBS and resuspended in medium without serum. After an overnight incubation in serum-free medium, cell viability was determined to be 495%, and the cells were resuspended in serum-free medium at 10 6 cells/ml in 96 well plates. The cells were treated for 60 min at 378C with indicated concentrations of wortmannin (Sigma), LY294002 (Biomol, Plymouth Meeting, PA, USA) or DMSO and then stimulated with 100 ng/ml G-CSF or 10% FCS/1% CS and incubated for 20 h in 378C and 5% CO 2 . The cells were then pulsed for 8 h with 1 mCi/well [ 3 H]-thymidine (New England Nuclear). Cells were harvested onto ®lter discs, dried, and measured by scintillation.
Statistical analysis
The GraphPad statistical software program (GraphPad, San Diego, CA, USA) was used to perform one-way analysis of variances on the samples. For comparisons between individual time points on a single cell line the TukeyKramer Multiple comparisons test was used.
